Volume 11, Number 3—March 2005
Research
Ebola Virus Antibody Prevalence in Dogs and Human Risk
Loïs Allela*, Olivier Bourry*, Régis Pouillot†, André Délicat*, Philippe Yaba*, Brice Kumulungui*, Pierre Rouquet*, Jean-Paul Gonzalez‡, and Eric M. Leroy*‡
Table 2
Prevalence rates of Ebola-specific immunoglobulin G antibodies in pet dogs from different areas and villages
| Area/village characteristic | No. | No. positive | Seroprevalence* (%) | 95% confidence interval (%) |
|---|---|---|---|---|
| France | 102 | 2 | 2 | 0.2–6.9 |
| Major towns (Libreville and Port Gentil) | 79 | 7 | 8.9 | 3.6–17.4 |
| Mekambo | 99 | 15 | 15.2 | 8.7–23.8 |
| Ebola virus–epidemic area (villages) | 159 | 40 | 25.2 | 18.6–32.6 |
| Villages with human cases | 92 | 25 | 27.2 | 18.4–37.4 |
| Villages without human cases | 67 | 15 | 22.4 | 13.1–34.2 |
| Villages with human cases and animal source | 66 | 21 | 31.8 | 20.9–44.4 |
| Villages with human cases, without animal source |
26 |
4 |
15.4 |
4.4–34.9 |
| *Seroprevalence rates were compared by using the Fisher exact test with a 0.05 confidence level. | ||||
¹Loïs Allela and Olivier Bourry contributed equally to this work.
